Acute Respiratory Distress Syndrome clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome
open to eligible people ages 18 years and up
This is a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of a single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion in patients with Acute…
Sacramento, California and other locations